Talphera (TLPH) Free Cash Flow (2010 - 2026)
Talphera's (TLPH) quarterly Free Cash Flow came in at -$3.4 million in Q1 2026, up 2.02% year-on-year from -$3.3 million in Q1 2025, and down 39.57% quarter-over-quarter from -$2.4 million in Q4 2025.
Talphera (TLPH) Free Cash Flow (2010 - 2026) Analysis & Trends
Talphera's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 2.02% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$11.3 million, a 14.89% increase from a year earlier, with the FY2025 full-year figure at -$11.4 million, up 10.4% from the prior year.
- Free Cash Flow retreated to -$3.4 million in Q1 2026 per TLPH's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.3 million in Q4 2024 and bottomed at -$9.0 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$3.5 million (2025), against an average of -$4.3 million.
- Across the five-year window, Free Cash Flow plunged 30.75% in 2022 and soared 46.11% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$5.5 million in 2022, then rose by 27.69% to -$3.9 million in 2023, then surged by 42.92% to -$2.3 million in 2024, then slipped by 8.07% to -$2.4 million in 2025, then slumped by 39.57% to -$3.4 million in 2026.
- Per Business Quant, the three latest TLPH Free Cash Flow figures stand at -$3.4 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | -3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.40 Mn |
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -2.44 Mn |
| Dec 31, 2025 | -2.44 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -2.95 Mn |
| Jun 30, 2025 | -2.95 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.94 Mn |
| Sep 30, 2024 | -2.94 Mn |
| Jun 30, 2024 | -4.61 Mn |
| Jun 30, 2024 | -4.61 Mn |
| Mar 31, 2024 | -2.88 Mn |
| Mar 31, 2024 | -2.88 Mn |
| Dec 31, 2023 | -3.95 Mn |
| Dec 31, 2023 | -3.95 Mn |